Porzio Life Sciences' Inaugural "State of Life Sciences Healthcare Compliance Survey"3/24/2016 | Article
Porzio Life Sciences, LLC ("PorzioLS"), a wholly-owned subsidiary of the law firm of Porzio, Bromberg & Newman, P.C. ("Porzio"), is dedicated to helping pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment.
In order to create a better understanding of the life sciences healthcare compliance environment and gain insight into how companies handle compliance challenges, PorzioLS has created the inaugural State of Life Sciences Healthcare Compliance Survey.
This survey is a compilation of the responses gathered from compliance professionals across a variety of life sciences companies, throughout all industry sectors and company sizes. The hope is that this data will serve as a useful benchmarking tool for life science compliance programs throughout the upcoming year.
To read the full survey results, please click here.
PorzioLS and Porzio work in tandem to provide regulatory compliance and legal and business services related to product development, the Prescription Drug Marketing Act, anti-kickback statutes, the Sunshine Act, Food and Drug Administration regulations, false claims act, ex-US industry codes and Office of Inspector General guidances. Together, the companies enhance the marketing and sales programs of a range of companies, including pharmaceutical and medical device manufacturers and distributors, virtual pharmaceutical companies, contract sales organizations, vendors to the life sciences industry, and wholesale distributors and labelers.